Cantor Fitzgerald Sticks to Its Buy Rating for US Physical Therapy


Cantor Fitzgerald analyst Joseph France maintained a Buy rating on US Physical Therapy (NYSE: USPH) today and set a price target of $90. The company’s shares closed yesterday at $91.90, close to its 52-week high of $95.20.

France commented:

“1Q18 results were in-line with our expectations, driven by a 7.4% jump in patient visits, new practices and a full quarter’s contribution from its workforce performance solutions business.”

According to TipRanks.com, France is a 4-star analyst with an average return of 9.2% and a 54.4% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Envision Healthcare.

US Physical Therapy has an analyst consensus of Moderate Buy, with a price target consensus of $80.67.

Find more picks by Best Performing Analysts >>

US Physical Therapy’s market cap is currently $1.16B and has a P/E ratio of 52.51. The company has a book value ratio of 5.6497.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. It provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company was founded in 1990 and is headquartered in Houston, TX.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts